Gilada Finance board to consider JV and NCD allotment on Jun 19

Gilada Finance and Investments Limited has scheduled a board meeting for June 19, 2026, to deliberate on entering into a strategic joint venture and approving the allotment of Non-Convertible Debentures (NCDs). The meeting will be held at 11:30 a.m. at the company's registered office to discuss these key business strategies and fundraising instruments.

The board will consider and approve the execution of the Joint Venture Agreement and related documents to formalize the strategic partnership. Additionally, the directors will evaluate and approve the allotment of NCDs to specific applicants, a move aimed at raising capital through debt instruments.

The meeting is being convened at a shorter notice period. The company stated that it is currently in the process of obtaining consent from all directors to ensure compliance with Section 173(3) of the Companies Act, 2013, which permits such meetings with necessary approvals.

Agenda Items

The board meeting will focus on the following primary matters:

Consideration and approval of entering into a Strategic Joint Venture.
Authorization for the execution of the Joint Venture Agreement and related documents.
Consideration and approval of the allotment of Non-Convertible Debentures (NCDs) to applicants.

The disclosure was made to BSE Limited under Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-1.77%	+12.42%	+12.33%	-5.27%	+15.71%	+55.97%

Gilada Finance and Investments Limited reported a net profit of ₹217.42 lakh for the financial year ended March 31, 2026, an increase from ₹212.96 lakh in the previous year. The company’s revenue from operations for FY26 stood at ₹725.57 lakh, up from ₹676.95 lakh in FY25. The board of directors approved the audited financial results for the quarter and year ended March 31, 2026, in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance

For the quarter ended March 31, 2026, the company recorded a net profit of ₹45.93 lakh, compared to ₹53.86 lakh in the corresponding quarter of the previous year. Revenue from operations for the quarter rose to ₹187.65 lakh from ₹179.05 lakh in the same period last year. Total income for the quarter was ₹189.95 lakh, while total expenses amounted to ₹126.48 lakh.

Key Financial Metrics for FY26

Particulars	FY26 (₹ Lakh)	FY25 (₹ Lakh)
Revenue from Operations	725.57	676.95
Total Income	743.59	710.04
Total Expenses	450.50	420.42
Profit Before Tax	293.09	289.62
Net Profit	217.42	212.96
Earnings Per Share (Basic)	1.55	1.52

Capital Allotment

The board approved the allotment of 15 Non-Convertible Debentures (NCDs) on a private placement basis, aggregating to ₹15 lakh. The allotment includes 4 cumulative NCDs amounting to ₹4 lakh and 11 non-cumulative NCDs amounting to ₹11 lakh. Both categories carry a coupon rate of 12.25% and have a tenure of 2 years. The date of allotment is May 28, 2026.

NCD Allotment Details

Particulars	Cumulative NCDs	Non-Cumulative NCDs
Number of NCDs	4	11
Amount	₹4 lakh	₹11 lakh
Rate of Interest	12.25%	12.25%
Tenure	2 Years	2 Years

Auditor and Governance

Bennur Nagaraja & Co, Chartered Accountants, audited the financial statements and issued an unmodified opinion. The report noted that the company has an adequate internal financial controls system over financial reporting that was operating effectively as of March 31, 2026. The board also appointed Sand and Associates as the Secretarial Auditor and M/s. Devaraj Chauhan & Associates as the Internal Auditor for the financial year 2026-27.